Dr. Daniele Amparore, PhD, specialized in urology in 2019 at the University of Turin, where he later earned an inter-athenaeum PhD in Bioengineering and Medical-Surgical Sciences, in collaboration with the Polytechnic University of Turin.
Since 2020, he has been doing clinical work as a urologist at the San Luigi Gonzaga University Hospital in Orbassano and as a consultant at the Candiolo IRCCS. His surgical practice focuses on minimally invasive surgery, particularly robot-assisted surgery, for the treatment of prostate, kidney, and urothelial malignancies. He also has extensive experience in the management of benign prostatic hypertrophy, using innovative techniques such as Aquabeam, iTIND, and Rezum.
University Research Professor of Urology since 2020 at the Department of Oncology, University of Turin, has been an Associate Professor of Urology in both the “Medicine and Surgery” and “Medical Radiology Imaging and Radiotherapy Techniques” degree programs since 2024
His scientific activity is mainly devoted to uro-oncology, with a focus on kidney cancer, technological innovations applied to minimally invasive surgery, and benign prostatic pathology.
He is the author of more than 180 publications in international scientific journals (H-index 31) and serves as a reviewer for more than 20 journals in the field. He is on the editorial board of the journal Minerva Urology and Nephrology.
Since 2025, he has been Chair of the Kidney Cancer Research Group of the Young Academic Urologists of the European Association of Urology (EAU).